bosentan anhydrous has been researched along with Hypertension, Renal in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lau, EM; McCaughan, GW; Torzillo, PJ | 1 |
| Bäcker, A; Bader, M; Cervenka, L; Dvorák, P; Ganten, D; Janda, J; Kopkan, L; Kramer, HJ; Malý, J; Opocenský, M; Tesar, V; Vanecková, I; Vernerová, Z | 1 |
| Clozel, JP; Donckier, J; Galanti, L; Hayashida, W; Ketelslegers, JM; Pouleur, H; Selvais, P; Stoleru, L; Van Mechelen, H | 1 |
| Davis, G; Hammad, FT; Wheatley, AM | 1 |
| Donckier, JE | 1 |
1 review(s) available for bosentan anhydrous and Hypertension, Renal
| Article | Year |
|---|---|
Therapeutic role of bosentan in hypertension: lessons from the model of perinephritic hypertension.
Topics: Animals; Bosentan; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Humans; Hypertension; Hypertension, Renal; Nitric Oxide; Receptors, Endothelin; Sulfonamides; Vasodilation | 2001 |
4 other study(ies) available for bosentan anhydrous and Hypertension, Renal
| Article | Year |
|---|---|
A case of portopulmonary hypertension spanning 18 years: successful use of bosentan for progressive disease after two liver transplantations.
Topics: Bosentan; Disease Progression; Female; Humans; Hypertension, Pulmonary; Hypertension, Renal; Liver Transplantation; Middle Aged; Sulfonamides; Time Factors; Treatment Outcome | 2012 |
Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive ren-2 transgenic rats.
Topics: Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Bosentan; Creatinine; Electrolytes; Endothelin Receptor Antagonists; Endothelin-1; Homozygote; Hypertension, Renal; Kidney; Male; Organ Size; Proteinuria; Rats; Rats, Sprague-Dawley; Renin; Sodium, Dietary; Sulfonamides | 2004 |
Role of endogenous endothelin-1 in experimental renal hypertension in dogs.
Topics: Animals; Blood Pressure; Bosentan; Dogs; Endothelins; Epinephrine; Heart Rate; Hypertension, Renal; Norepinephrine; Sulfonamides | 1995 |
Long-term renal effects of unilateral ureteral obstruction and the role of endothelin.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Captopril; Endothelins; Hypertension, Renal; Male; Rats; Rats, Wistar; Sulfonamides; Ureteral Obstruction; Urodynamics; Vasoconstrictor Agents | 2000 |